Evidence map›Paper›PMID 36201400›Full record

ArticleMMWR. Morbidity and mortality weekly report2022

Increase in Acute Respiratory Illnesses Among Children and Adolescents Associated with Rhinoviruses and Enteroviruses, Including Enterovirus D68 - United States, July-September 2022.

Kevin C Ma, Amber Winn, Heidi L Moline, Heather M Scobie, Claire M Midgley, Hannah L Kirking, Jennifer Adjemian, Kathleen P Hartnett, Dylan Johns, Jefferson M Jones and 11 more

Open access · diamondAbstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Risks and benefits of face masks in children.Frontiers in pediatrics · 2026
    Review
  13. Article
  14. Article
  15. Prevalence and epidemiology of enterovirus species in a pediatric oncology patient population.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2025
    Article
  16. Article
  17. Article
  18. Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Review
  19. Article
  20. Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence.The journal of allergy and clinical immunology. In practice · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kevin C Ma
Amber Winn
Heidi L Moline
Heather M Scobie
Claire M Midgley
Hannah L Kirking
Jennifer Adjemian
Kathleen P Hartnett
Dylan Johns
Jefferson M Jones
Adriana Lopez
Xiaoyan Lu
Ariana Perez
Cria G Perrine
Andzelika E Rzucidlo
Meredith L McMorrow
Benjamin J Silk
Zachary Stein
Everardo Vega
New Vaccine Surveillance Network Collaborators
Aron J Hall

Funding

Surveillance for Vaccine Preventable Disease in ChildrenU01IP001150 · IP · BAYLOR COLLEGE OF MEDICINE · PI BOOM, JULIE ANNE, SAHNI, LEILA C · 2021 to 2025
$11.2M
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine EffectivenessU01IP001158 · IP · UNIVERSITY OF ROCHESTER · PI WEINBERG, GEOFFREY ALAN · 2021 to 2025
$10.2M
NCIRD CDC HHS U01 IP001150NCIRD CDC HHS U01 IP001158
6 · The paper itself

Abstract

Increases in severe respiratory illness and acute flaccid myelitis (AFM) among children and adolescents resulting from enterovirus D68 (EV-D68) infections occurred biennially in the United States during 2014, 2016, and 2018, primarily in late summer and fall. Although EV-D68 annual trends are not fully understood, EV-D68 levels were lower than expected in 2020, potentially because of implementation of COVID-19 mitigation measures (e.g., wearing face masks, enhanced hand hygiene, and physical distancing) (1). In August 2022, clinicians in several geographic areas notified CDC of an increase in hospitalizations of pediatric patients with severe respiratory illness and positive rhinovirus/enterovirus (RV/EV) test results.* Surveillance data were analyzed from multiple national data sources to characterize reported trends in acute respiratory illness (ARI), asthma/reactive airway disease (RAD) exacerbations, and the percentage of positive RV/EV and EV-D68 test results during 2022 compared with previous years. These data demonstrated an increase in emergency department (ED) visits by children and adolescents with ARI and asthma/RAD in late summer 2022. The percentage of positive RV/EV test results in national laboratory-based surveillance and the percentage of positive EV-D68 test results in pediatric sentinel surveillance also increased during this time. Previous increases in EV-D68 respiratory illness have led to substantial resource demands in some hospitals and have also coincided with increases in cases of AFM (2), a rare but serious neurologic disease affecting the spinal cord. Therefore, clinicians should consider AFM in patients with acute flaccid limb weakness, especially after respiratory illness or fever, and ensure prompt hospitalization and referral to specialty care for such cases. Clinicians should also test for poliovirus infection in patients suspected of having AFM because of the clinical similarity to acute flaccid paralysis caused by poliovirus. Ongoing surveillance for EV-D68 is critical to ensuring preparedness for possible future increases in ARI and AFM.

Indexed as

AsthmaCOVID-19Enterovirus D, HumanEnterovirus InfectionsMyelitisRespiratory Tract InfectionsAdolescentCentral Nervous System Viral DiseasesChildDisease OutbreaksHumansNeuromuscular DiseasesRhinovirusUnited States

Identifiers

PMID36201400
PMCPMC9541033
OpenAlexW4297384220

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.